About Us
   

  Manufacturing
   

  Quality
   

  R&D
   

  Products
   

  Marketing
   

  News Room
   

  Enquiry Form
   

  Order Form
   

  Opportunities
   

  Sitemap
   

  Contact Us
   
 
   
 
   
SPARTI
Sparfloxacin Tablets
 
Description

It is an aminofluroquinoline and exerts its antibacterial activity vis the inhibition of DNA replication of bacteria by inhibiting DNA gyrase activity. Its absorption begins soon after oral administration. The distribution of sparfloxacin in nasal mucosa and sinus mucosa is primarily high. It is metabolised by the liver to an inactive acylglucuronide conjugate. The terminal plasma elimination half-life is about 20 Hrs. Elimination of sparfloxacin is complete.

Composition

Each Film coated Tablet Contains:Sparfloxacin 200mg.Color : Red Oxide of Iron

Indications

Pneumonia, acute exacerbation of chronic bronchitis, lower respiratory tract infection, acute sinusitis, gonococcal and non-gonococcal urethritis in males.

Dosage

Lower respiratory tract infections: 400mg as single dose on the first day followed by 200mg each day for 10 days.

Pack

: 5 Blisters of 10 Tablets each